Can you hear me now?: The Tipline for 21 August 2018

Verizon is calling for the Supreme Court to elaborate on the scope of its American Express ruling, which it issued less than two months ago. Meanwhile, Mylan and Pfizer have successfully dismissed some of the antitrust claims brought against them, but consumers’ main accusation of EpiPen monopolisation remains intact. We also have news on eight more restaurant chains removing “no poach” language from their franchise contracts, and the New York Times endorsing an antitrust scholar to be the next attorney general of New York.

Get unlimited access to all Global Competition Review content